Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
Eric Van Cutsem(KU Leuven), Fernando Rivera(Marqués de Valdecilla University Hospital), Scott Berry(Sunnybrook Health Science Centre), Albrecht Kretzschmar(Helios Hospital Berlin-Buch), M. Michael(Peter MacCallum Cancer Centre), M. DiBartolomeo(Fondazione IRCCS Istituto Nazionale dei Tumori), M. Mazier(PAREXEL International (France)), J.-L. Canon(Queen Fabiola Children's University Hospital), Vassilis Georgoulias(University Hospital of Heraklion), Marc Peeters(Ghent University Hospital), John Bridgewater(University College Hospital), David Cunningham(Royal Marsden Hospital)
Cited by 534
Abstract
Related Papers
No related papers found
Powered by citation graph analysis